Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinji Gel is a topical traditional Chinese medicine (TCM) formulation specifically indicated for the treatment of gynecological inflammatory conditions, including chronic pelvic inflammatory disease (PID), endometritis, and various forms of vaginitis. Developed and manufactured in China, the gel is composed of a proprietary blend of herbal extracts, most notably *Rosa laevigata*, *Milletia dielsiana*, *Zanthoxylum nitidum*, and *Andrographis paniculata*. These botanical components work synergistically to provide anti-inflammatory, antimicrobial, and analgesic effects. The formulation is designed to clear heat, resolve toxins, and promote local blood circulation to alleviate symptoms such as pelvic pain, abnormal vaginal discharge (leukorrhea), and local irritation. It is typically administered intravaginally to target the site of inflammation directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jinji Gel.